ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RGLS Regulus Therapeutics Inc

2.025
0.115 (6.02%)
Last Updated: 13:33:42
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -6.57M-7.18M-7.56M-6.93M-7.37M-7.32M-8.13M-8.3M
Pre Tax Income -6.72M-7.26M-7.55M-6.8M-7.14M-7.01M-7.82M-8.06M
Net Income -6.72M-7.26M-7.55M-6.8M-7.14M-7.01M-7.82M-8.06M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -6.57M-7.18M-7.56M-6.93M-7.37M-7.32M-8.13M-8.3M
EBITDA -6.54M-7.14M-7.53M-6.9M-7.32M-7.27M-8.07M-8.22M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.19M72k72k6.83M10.01M000
Operating Income -81.5M-70.13M-46.76M-16.83M-14.16M-27.82M-28.24M-31.11M
Pre Tax Income -81.84M-72.1M-48.65M-18.59M-15.73M-27.81M-28.32M-30.04M
Net Income -81.84M-71.91M-48.71M-18.59M-15.73M-27.81M-28.32M-30.04M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.546-0.692-5.524-0.885-0.233-0.191-1.682-1.185
EBIT -81.5M-70.13M-46.76M-16.83M-14.16M-27.82M-28.24M-31.11M
EBITDA -79.23M-67.61M-44.5M-15.9M-13.69M-27.36M-28.12M-30.88M

Your Recent History

Delayed Upgrade Clock